The conditions of use of news releases conform to the terms of use governing the investor relations pages.

Archives

2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000

2007

	Nov/27/2007		Taisho and Taisho Business Research Institute Sign a Summary Absorption-type Merger Agreement
	Nov/9/2007		Presentation of Fiscal 2007 First Half Results
	Nov/7/2007		Financial Results for the First Half of Fiscal 2007 / Reference Data
	Oct/30/2007		Taisho and Pfizer Sign a Letter of Intent for Taisho's Schizophrenia Drug Candidate
	Oct/10/2007		Taisho Revises Earnings Forecasts for FY2007 First Half and Full Year
	Oct/5/2007		Annual Report 2007
	Oct/5/2007		Investors' Guide 2007
	Oct/4/2007		Launch of Geninax(R) Tablet, an Oral New-Type Quinolone Antibacterial Agent
	Sep/27/2007		License Agreement for Taisho’s New Drug Candidates of CNS Indications
	Jul/31/2007		Presentation of Fiscal 2007 First Quarter Results
	Jul/30/2007		Financial Results for the First Quarter of Fiscal 2007 / Reference Data
	May/17/2007		Presentation of Fiscal 2006 Results
	May/15/2007		Financial Results for Fiscal 2006 / Reference Data
	May/7/2007		License Agreement for NM-702, a Drug for the Treatment of Arteriosclerosis Obliterans
	Mar/26/2007		Taisho Repurchases Treasury Stock on the Open Market, Ends Buyback Program
	Mar/9/2007		Taisho to Repurchase Treasury Stock
	Mar/1/2007		Taisho Repurchases Treasury Stock on the Open Market, Ends Buyback Program
	Feb/1/2007		Taisho to Repurchase Treasury Stock on the Open Market
	Feb/1/2007		Presentation of Fiscal 2006 Third Quarter Results
	Jan/31/2007		Taisho Revises Earnings Forecasts for FY2006 Full Year
	Jan/31/2007		Financial Results for the Third Quarter of Fiscal 2006 / Reference Data

Adobe Reader is required to view these files. Adobe Reader is distributed free of charge by Adobe Systems Incorporated.

Page Top